| San Diego Biotechnology Network

News Ticker

[ July 17, 2019 ] Halozyme Announces First Clinical Dosing In argenx’s Phase 1 Trial Of Efgartigimod (ARGX-113) With ENHANZE® Drug Delivery Technology News
[ July 17, 2019 ] Tocagen Inc.: Associate Director, Quality Control/Technology San Diego Biotech Jobs
[ July 16, 2019 ] Bristol-Myers Squibb Company: Community Product Specialist I-O San Diego Biotech Jobs
[ July 16, 2019 ] (Assoc.) Director of CMC Supply Chain – Synthorx, Inc. – La Jolla, CA San Diego Biotech Jobs
[ July 16, 2019 ] Associate Director of Late-Stage Analytics and Bioassay Development – Synthorx, Inc. – La Jolla, CA San Diego Biotech Jobs

Artelo Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update

July 15, 2019 sandiegobiotech Comments Off

LA JOLLA, Calif., July 15, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial resu… […]

NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results

July 15, 2019 sandiegobiotech Comments Off

SAN DIEGO, July 15, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company wil… […]

Cibus Issued New Patent For Increasing Efficiency Of Gene-Editing In Plants

July 15, 2019 sandiegobiotech Comments Off

— Further Extends Cibus Intellectual Property for its Precise Gene-Editing Technologies —

SAN DIEGO, July 15, 2019 /PRNewswire/ — Cibus, a leader in advanced plant-breeding technologies, today announced it has been granted a new patent related to … […]

Trovagene Commences Non-Deal Investor Roadshow

July 15, 2019 sandiegobiotech Comments Off

Management team to meet with investment institutions, analysts and shareholders in NYC to provide an overview of the Company and its advancing clinical development of onvansertib

SAN DIEGO, July 15, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV)… […]

Biotech notebook: Cancer discovery, bacterial syringes and organoids

July 13, 2019 sandiegobiotech Comments Off

Organoids symposium meets in San Diego in late August […]

Illumina falls on disappointing revenue forecast

July 12, 2019 sandiegobiotech Comments Off

Biotech giant loses $8 billion in market value […]

MediciNova Announces Phase 3 Clinical Trial Plan for MN-166 (ibudilast) in Progressive MS

July 12, 2019 sandiegobiotech Comments Off

LA JOLLA, Calif., July 11, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced its plans for a … […]

Cytori to Present Corporate Update & New Strategic Direction

July 12, 2019 sandiegobiotech Comments Off

SAN DIEGO, July 11, 2019 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (NASDAQ: CYTX) “the Company” will provide a live webcast to discuss its new company direction following two recent asset sales and highlight key anticipated milestones on July 15,… […]

STAT Plus: Illumina earnings points to worrying signs for consumer genetics industry

July 12, 2019 sandiegobiotech Comments Off

If you look closely at Thursday’s bad news from Illumina, the multibillion-dollar standard-bearer of the genomics industry, you might see a worrisome sign for the consumer genetics industry. […]

Salk Institute scientists get to the root of plant growth

July 11, 2019 sandiegobiotech Comments Off

Gene that controls how deep roots grow could be used in Salk Institute climate initiative, making crops hardier […]